Nasdaq Ubx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq ubx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Ubx Today - Breaking & Trending Today

Unity Biotechnology (NASDAQ:UBX) Stock Rating Upgraded by Wedbush

Wedbush upgraded shares of Unity Biotechnology (NASDAQ:UBX – Free Report) from a neutral rating to an outperform rating in a research note released on Thursday morning, Marketbeat Ratings reports. The firm currently has $4.00 target price on the stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $10.00 price target on shares of […] ....

Acadian Asset Management , Geode Capital Management , Vanguard Group Inc , Unity Biotechnology Inc , Unity Biotechnology Company Profile , Renaissance Technologies , Unity Biotechnology , Free Report , Marketbeat Ratings , Biotechnology Stock Down , Asset Management , Street Corp , Capital Management , Get Free Report , Unity Biotechnology Daily , Nasdaq Ubx ,

Head-To-Head Analysis: Unity Biotechnology (NASDAQ:UBX) versus Mallinckrodt (OTCMKTS:MNKKQ)

Unity Biotechnology (NASDAQ:UBX – Get Free Report) and Mallinckrodt (OTCMKTS:MNKKQ – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends. Valuation & Earnings This table compares Unity Biotechnology […] ....

United States , South San Francisco , Us Bankruptcy Court , Unity Biotechnology Inc , Forge Inc , Unity Biotechnology , Get Free Report , Given Unity Biotechnology , Middle East , Specialty Brands , Acthar Gel , Silence Therapeutics , Unity Biotechnology Daily , Nasdaq Ubx , Stock Comparison , Stock Analysis ,

Unity Biotechnology (NASDAQ:UBX) Given New $6.00 Price Target at Citigroup

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […] ....

United Kingdom General , United Kingdom , Jan Van Deursen , Judith Campisi , Nathaniel Eames David , Blackrock Inc , Unity Biotechnology Inc , Arete Wealth Advisors , Unity Biotechnology Company Profile , Geode Capital Management , Unity Biotechnology , Get Rating , Wealth Advisors , Street Corp , Capital Management , Sigma Investments , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,

Unity Biotechnology, Inc. (NASDAQ:UBX) Short Interest Update

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 952,200 shares, a drop of 17.2% from the April 30th total of 1,150,000 shares. Based on an average daily trading volume, of 417,800 shares, the days-to-cover ratio […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology Inc , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx ,

Citigroup Boosts Unity Biotechnology (NASDAQ:UBX) Price Target to $6.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective boosted by Citigroup from $5.00 to $6.00 in a research report sent to investors on Friday morning, The Fly reports. Several other research firms also recently commented on UBX. Mizuho dropped their price objective on shares of Unity Biotechnology from $12.00 to $6.00 and set […] ....

Jan Van Deursen , Nathaniel Eames David , Judith Campisi , Unity Biotechnology Inc , Unity Biotechnology Company Profile , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,